Skip to main content

Table 1 Common examples of preclinical in vivo models of inflammation that have been used to assess in vivo markers of pre-clinical efficacy and/or in vitro MSC potency

From: Comparison of freshly cultured versus freshly thawed (cryopreserved) mesenchymal stem cells in preclinical in vivo models of inflammation: a protocol for a preclinical systematic review and meta-analysis

Models of inflammation
Sepsis
Acute lung injury
Inflammatory airway disease
Ischemia-reperfusion injury
Acute and chronic arthritis
Chronic kidney disease
Hindlimb ischemia
Closure of acute and chronic skin wounds